Short-term use of rofecoxib increases the risk for adverse cardiovascular events

被引:0
|
作者
机构
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:621 / 621
相关论文
共 50 条
  • [31] Dilation of Pediatric Eosinophilic Esophagitis: Adverse Events and Short-term Outcomes
    Menard-Katcher, Calies
    Furuta, Glenn T.
    Kramer, Robert E.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (05): : 701 - 706
  • [32] Short-term outcome and predictors of adverse events following pulmonary thromboendarterectomy
    Gilbert, TB
    Gaine, SP
    Rubin, LJ
    Sequeira, AJ
    WORLD JOURNAL OF SURGERY, 1998, 22 (10) : 1029 - 1032
  • [33] Use of Different Formulations Rivastigmine and Risk of Cardiovascular Adverse Events
    Lai, Edward Chia-Cheng
    Wong, Monera B.
    Iwata, Isao
    Zhang, Yinghong
    Hsieh, Cheng-Yang
    Yang, Yea-Huei Kao
    Setoguchi, Soko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 354 - 354
  • [34] Risk Factors for Short-term Adverse Events and Readmission After Arthroscopic Meniscectomy Does Age Matter?
    Basques, Bryce A.
    Gardner, Elizabeth C.
    Varthi, Arya G.
    Fu, Michael C.
    Bohl, Daniel D.
    Golinvaux, Nicholas S.
    Grauer, Jonathan N.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2015, 43 (01): : 169 - 175
  • [35] Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users
    Brophy, James M.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (08)
  • [36] Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
    Juni, P
    Nartey, L
    Reichenbach, S
    Sterchi, R
    Dieppe, PA
    Egger, M
    LANCET, 2004, 364 (9450): : 2021 - 2029
  • [37] Examining prognostic scores for short-term major adverse cardiovascular events prediction following primary PCI: a comparative analysis
    Safdar, U.
    Kumar, R.
    Sial, J.
    Saghir, T.
    Karim, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [38] Examining Prognostic Scores for Short-Term Major Adverse Cardiovascular Events Prediction After Primary PCI: A Comparative Analysis
    Kumar, Rajesh
    Sial, Jawaid
    Khan, Naveedullah
    Kumar, Ashok
    Karim, Musa
    Hakeem, Abdul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B328 - B328
  • [39] Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study
    Bjorn Gudbjornsson
    Sigurdur B. Thorsteinsson
    Helgi Sigvaldason
    Rannveig Einarsdottir
    Magnus Johannsson
    Helga Zoega
    Matthias Halldorsson
    Gudmundur Thorgeirsson
    European Journal of Clinical Pharmacology, 2010, 66 : 619 - 625
  • [40] IMPACT OF BIOMARKERS ON SHORT-TERM RISK PREDICTION OF GLOBAL CARDIOVASCULAR EVENTS IN OLDER ADULTS: ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY
    Saeed, Anum
    Nambi, Vijay
    Sun, Wensheng
    Virani, Salim
    Deswal, Anita
    Hoogeveen, Ron
    Wagenknecht, Lynne
    Taffet, George
    Matsushita, Kunihiro
    Selvin, Elizabeth
    Coresh, Josef
    de Lemos, James
    Ballantyne, Christie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 2668 - 2668